Researchers at the University of Iowa found that adding high-dose IV vitamin C to chemotherapy helped increase survival in ...

Patients with locally advanced pancreatic cancer demonstrated a two-month difference in survival with tumor-treating fields ...

Novocure said on Monday its experimental therapy extended the lives of patients with a form of advanced pancreatic cancer when combined with chemotherapy, achieving the primary goal in a late-stage ...

We talked last week about finding pancreatic cancer as early as possible, sometimes even before it forms and surgeons can ...

In a Phase III clinical trial, a therapy known as Tumor Treating Fields (TTFields) increased survival for patients whose ...

The phase 3 PANOVA-3 trial, designed to evaluate concomitant treatment with tumor treating fields and chemotherapy, met its ...

Novocure’s positive phase 3 results boost pancreatic cancer treatment prospects. Read why NVCR stock is worth watching with ...

NovoCure's TTFields therapy, combined with standard chemotherapy, improves overall survival in advanced pancreatic cancer.

StudyFinds' Dr. Faith Coleman speaks with the doctor testing a new vitamin C treatment that may double the survival time of ...

Novocure stock soars 49% as the late-stage study of TTFields therapy for treating pancreatic adenocarcinoma meets the primary ...

The hardest part of Sudarshan "Sudsie" Maharaj's battle with pancreatic cancer was not surgery to remove his gallbladder and ...

Using tumor-treating fields alongside chemotherapy improved patient survival, Novocure said. Elsewhere, Cytokinetics got a ...